Simultaneous examination of sister chromatid exchanges and cell replication kinetics in tumor and normal cells in vivo.
The bromodeoxyuridine differential chromatid labeling techniques were applied to the simultaneous in vivo examination of cell cycle kinetics and sister chromatid exchange (SCE) induction by various cancer chemotherapeutic agents in normal and Ehrlich ascites tumor cell populations. Compounds which yielded high ratios of SCE (in tumor cells):SCE (in normal cells) also produced greater inhibition of cellular replication in tumor cells when compared to normal cells. Thus, this approach permits in vivo assessment of induction of DNA damage by SCE analysis as well as inhibition of cellular replication by specific cancer chemotherapeutic agents in tumor and normal cell populations.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001854:Bone Marrow Cells; D002286:Carcinoma, Ehrlich Tumor; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured / Q000502:physiology*; D003434:Crossing Over, Genetic / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects; D008297:Male; D051379:Mice; D012854:Sister Chromatid Exchange / Q000187:drug effects
D000970:Antineoplastic Agents